Latin America News Hub
SEE OTHER BRANDS

Your daily news update on Latin America

Latin America News Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America News Hub.

Press releases published on May 6, 2025

 Italfarmaco Announces U.S. FDA Grants Fast Track Designation to Givinostat in Treatment of Polycythemia Vera

Italfarmaco Announces U.S. FDA Grants Fast Track Designation to Givinostat in Treatment of Polycythemia Vera

MILAN, Italy, May 6, 2025 – Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to givinostat for the treatment of patients with polycythemia vera (PV), a rare haematologic cancer, for …

Integral Metals Reports Monazite-Dominant REE Mineralization at Woods Creek

Integral Metals Reports Monazite-Dominant REE Mineralization at Woods Creek

CALGARY, Alberta, May 06, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to report detailed mineralogical analysis by Quantitative Evaluation of Materials by Scanning (QEMSCAN) …

Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy

Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy

Angelini Ventures marks its first investment in the cardiovascular and gene therapy space – and first in Asia, further diversifying its strong and growing portfolio Rome, Italy - 6 May 2025 – Angelini Ventures, the corporate venture firm of Angelini …

Novaremed Announces Completion of Enrollment in NIH-sponsored Phase 2b Study with Non-opioid NRD.E1 for the Treatment of Chronic Pain Associated with Diabetic Peripheral Neuropathy

Novaremed Announces Completion of Enrollment in NIH-sponsored Phase 2b Study with Non-opioid NRD.E1 for the Treatment of Chronic Pain Associated with Diabetic Peripheral Neuropathy

Last patient first visit (LPFV) marks completion of enrollment of 127 adult and elderly patients in the randomized, placebo-controlled trial -- topline data is expected in Q4 2025 This study builds on Phase 2a proof-of-concept results, which showed a …

Grupo Aeroportuario Del Pacifico Announces Debt Securities “GAP 21” Payment

Grupo Aeroportuario Del Pacifico Announces Debt Securities “GAP 21” Payment

GUADALAJARA, Mexico, May 05, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE:PAC; BMV: GAP) (“the Company” or “GAP”) announces that on Friday, May 2, 2025, the payment corresponding to the maturity of the debt securities “ …

Discovery Files Final Base Shelf Prospectus

Discovery Files Final Base Shelf Prospectus

TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) is pleased to announce that it has filed a final short form base shelf prospectus (the “Shelf Prospectus”) with the securities …

Aura Declares Dividend of US$0.40 per share and US$0.1333 per BDR based on Q1 2025 Results, resulting in a Dividend Yield of 11%¹ in the LTM

Aura Declares Dividend of US$0.40 per share and US$0.1333 per BDR based on Q1 2025 Results, resulting in a Dividend Yield of 11%¹ in the LTM

ROAD TOWN, British Virgin Islands, May 05, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA, B3: AURA33 and OTCQX: ORAAF) (“Aura” or the “Company”) announced today that the Company’s Board of Directors (the “Board”) has declared and approved the …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service